the dopamine-beta-hydroxylase inhibitor diethyldithiocarbamate ( ddc ) , administered 2 h before [ 3h ] e2 to reduce levels of only ne and ep , increased the total and specific uptake of [ 3h ] e2 by 62-140 % in nuclear and supernatant fractions of the anterior pituitary and also increased uptake in several brain areas .
C0028351
ne
C0014563
ep